DPP-IV Inhibitors

All categories
DBCAT002653Therapeutic categoryA10BH

Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and... A DrugBank category of 15 drugs. 5 of them are approved.

ATC classification
Part of
Blood Glucose Lowering Agents
Also known as
Adenosine Deaminase Complexing Protein 2 Inhibitor · Adenosine Deaminase Complexing Protein-2 Inhibitor · Dipeptidyl Peptidase 4 (dpp-4) Inhibitors · Dipeptidyl Peptidase 4 Inhibitors · Dipeptidyl Peptidase IV Inhibitors
Drugs

What you can answer from here — as of August 12, 2019

15DrugsEach linked to its full drug card
Listed above
2Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,861Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do DPP-IV Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In